Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B

Scott Patterson; Jacob George; Simone Strasser; Alice Lee; William Sievert; Amanda Nicoll; Paul Desmond; Stuart Roberts; Stephen Locarnini; Scott Bowden; Peter Angus

doi:10.1136/gut.2010.223206

Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B

Scott Patterson
, Jacob George
, Simone Strasser
, Alice Lee
, William Sievert
, Amanda Nicoll
, Paul Desmond
, Stuart Roberts
, Stephen Locarnini
, Scott Bowden
, Peter Angus

Medicine Monash Health

Research output: Contribution to journal › Article › Research › peer-review

156 Citations (Scopus)

Abstract

To determine the efficacy of tenofovir disoproxil fumarate (TDF) in adults with chronic hepatitis B virus (HBV) infection who had previously failed lamivudine (LAM) and had significant viral replication (HBV DNA >10a?? copies/ml if HBeAg positive, > 10a? copies/ml if HBeAg negative) despite at least 24 weeks of treatment with adefovir dipivoxil (ADV).

Original language	English
Pages (from-to)	247 - 254
Number of pages	8
Journal	Gut
Volume	60
Issue number	2
DOIs	https://doi.org/10.1136/gut.2010.223206
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1136/gut.2010.223206

Cite this

@article{ce8e6e9120c94310bbff4a1459670016,

title = "Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B",

abstract = "To determine the efficacy of tenofovir disoproxil fumarate (TDF) in adults with chronic hepatitis B virus (HBV) infection who had previously failed lamivudine (LAM) and had significant viral replication (HBV DNA >10a?? copies/ml if HBeAg positive, > 10a? copies/ml if HBeAg negative) despite at least 24 weeks of treatment with adefovir dipivoxil (ADV).",

author = "Scott Patterson and Jacob George and Simone Strasser and Alice Lee and William Sievert and Amanda Nicoll and Paul Desmond and Stuart Roberts and Stephen Locarnini and Scott Bowden and Peter Angus",

year = "2011",

doi = "10.1136/gut.2010.223206",

language = "English",

volume = "60",

pages = "247 -- 254",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ",

number = "2",

}

TY - JOUR

T1 - Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B

AU - Patterson, Scott

AU - George, Jacob

AU - Strasser, Simone

AU - Lee, Alice

AU - Sievert, William

AU - Nicoll, Amanda

AU - Desmond, Paul

AU - Roberts, Stuart

AU - Locarnini, Stephen

AU - Bowden, Scott

AU - Angus, Peter

PY - 2011

Y1 - 2011

N2 - To determine the efficacy of tenofovir disoproxil fumarate (TDF) in adults with chronic hepatitis B virus (HBV) infection who had previously failed lamivudine (LAM) and had significant viral replication (HBV DNA >10a?? copies/ml if HBeAg positive, > 10a? copies/ml if HBeAg negative) despite at least 24 weeks of treatment with adefovir dipivoxil (ADV).

AB - To determine the efficacy of tenofovir disoproxil fumarate (TDF) in adults with chronic hepatitis B virus (HBV) infection who had previously failed lamivudine (LAM) and had significant viral replication (HBV DNA >10a?? copies/ml if HBeAg positive, > 10a? copies/ml if HBeAg negative) despite at least 24 weeks of treatment with adefovir dipivoxil (ADV).

UR - http://gut.bmj.com/content/60/2/247.full.pdf+html

U2 - 10.1136/gut.2010.223206

DO - 10.1136/gut.2010.223206

M3 - Article

SN - 0017-5749

VL - 60

SP - 247

EP - 254

JO - Gut

JF - Gut

IS - 2

ER -

Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B

Abstract

UN SDGs

Access to Document

Other files and links

Cite this